Rundu Pharmaceutical Gets Regulatory Nod to Add Specification for Irbesartan Tablets

MT NewswiresNov 14 00:37 ET

Zhuhai Rundu Pharmaceutical's (SZSE:002923) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Simply Wall StNov 4 17:42 ET

Rundu Pharma Gets Active Pharmaceutical Ingredient Approval for Arthritis Drug

MT NewswiresNov 4 06:27 ET

Zhuhai Rundu Pharmaceutical (002923.SZ): Hydroxychloroquine Sulfate has obtained the approval notice for the application for listing of chemical raw materials.

zhuhai rundu pharmaceutical (002923.SZ) announced that the company recently received the approval and issuance of hydroxy... by the National Medical Products Administration.

Zhitong FinanceNov 3 03:22 ET

Rundu shares: report for the third quarter of 2024

SZSIOct 28 12:00 ET · Announcements

Zhuhai Rundu Pharmaceutical (002923.SZ) released its performance for the first three quarters, with a net income of 37.1805 million yuan, a year-on-year decrease of 43.29%.

Zhuhai Rundu Pharmaceutical (002923.SZ) released the report for the first three quarters of 2024, during the reporting period the company achieved revenue...

Zhitong FinanceOct 28 11:50 ET